Search hospitals > Washington > Seattle
Fred Hutchinson Cancer Research Center
Claim this profileSeattle, Washington 98109
Global Leader in Cancer
Global Leader in T-Lymphoblastic Leukemia/Lymphoma
Conducts research for Lymphoma
Conducts research for Acute Myeloid Leukemia
Conducts research for Myeloid Leukemia
818 reported clinical trials
106 medical researchers
Summary
Fred Hutchinson Cancer Research Center is a medical facility located in Seattle, Washington. This center is recognized for care of Cancer, T-Lymphoblastic Leukemia/Lymphoma, Lymphoma, Acute Myeloid Leukemia, Myeloid Leukemia and other specialties. Fred Hutchinson Cancer Research Center is involved with conducting 818 clinical trials across 982 conditions. There are 106 research doctors associated with this hospital, such as Michael J Wagner, MD, Michael Schweizer, Christina S. Baik, and Jennifer M. Specht.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2T-Lymphoblastic Leukemia/Lymphoma
Global LeaderHLA positive
HLA-A positive
HLA negative
Top PIs
Michael J Wagner, MDDana-Farber Cancer Institute5 years of reported clinical research
Studies Liposarcoma
Studies Cancer
15 reported clinical trials
19 drugs studied
Michael SchweizerFred Hutch/University of Washington Cancer Consortium1 year of reported clinical research
Expert in Prostate Cancer
Studies Cancer
14 reported clinical trials
27 drugs studied
Christina S. BaikFred Hutchinson Cancer Center5 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
12 reported clinical trials
19 drugs studied
Jennifer M. SpechtSeattle Cancer Care Alliance / University of Washington3 years of reported clinical research
Studies Breast Cancer
Studies Cancer
10 reported clinical trials
18 drugs studied
Clinical Trials running at Fred Hutchinson Cancer Research Center
Breast Cancer
Cancer
Multiple Myeloma
Breast cancer
Ovarian Cancer
Prostate Cancer
Pancreatic Cancer
Lung Cancer
Plasma Cell Neoplasm
Acute Myeloid Leukemia
Letrozole
for Breast Cancer
This stage IV trial examines how a mutation in HSD3B1 (1245C) gene affects treatment of stage I-III breast cancer. This trial may help researchers determine if mutations in HSD3B1 decreases the efficacy of aromatase inhibitor therapy such as letrozole. Letrozole may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Recruiting3 awards Phase 410 criteria
Cancer Vaccine
for Triple Negative Breast Cancer
This trial studies the effect of a special vaccine called STEMVAC, given with sargramostim, in patients with a hard-to-treat type of breast cancer. The vaccine helps the immune system recognize and attack cancer cells. The goal is to see how well the immune system responds to this treatment. STEMVAC is a type of cancer vaccine designed to stimulate the immune system to recognize and attack cancer cells.
Recruiting2 awards Phase 218 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Fred Hutchinson Cancer Research Center?
Fred Hutchinson Cancer Research Center is a medical facility located in Seattle, Washington. This center is recognized for care of Cancer, T-Lymphoblastic Leukemia/Lymphoma, Lymphoma, Acute Myeloid Leukemia, Myeloid Leukemia and other specialties. Fred Hutchinson Cancer Research Center is involved with conducting 818 clinical trials across 982 conditions. There are 106 research doctors associated with this hospital, such as Michael J Wagner, MD, Michael Schweizer, Christina S. Baik, and Jennifer M. Specht.
Where is Fred Hutchinson Cancer Research Center located?
**Fred Hutchinson Cancer Research Center**
- **Address:** 1100 Fairview Ave N, Seattle, WA 98109
- **Directions:** From downtown Seattle, take the South Lake Union Streetcar to the Westlake Ave N & Mercer St stop. From there, it's a 10-minute walk northwest on Fairview Ave N.
Who should I call to ask about financial aid or insurance network?
**Fred Hutchinson Cancer Research Center Financial Assistance and Insurance Departments**
- **Financial Counseling Department**
- **Address:** 825 Eastlake Ave. East, Seattle, Washington, 98109
- **Phone:** (206) 606-6226 or toll-free at 1 (800) 304-1763
- **Email:** fincounsel@fredhutch.org
- **Website:** [Financial Assistance Information](https://www.fredhutch.org/en/patient-care/patient-services/insurance-and-billing/financial-assistance.html)
- **Patient Financial Services Department**
- **Phone:** (206) 606-6226 or toll-free at 1 (800) 304-1763
- **Email:** fincounsel@fredhutch.org
- **Website:** [Financial Assistance Information](https://www.fredhutch.org/en/patient-care/patient-services/insurance-and-billing/financial-assistance.html)
These departments offer support with financial assistance applications, insurance queries, and billing issues.
What insurance does Fred Hutchinson Cancer Research Center accept?
The Fred Hutchinson Cancer Research Center accepts a wide range of insurance plans, including but not limited to Aetna, Allways Health Partners, Ambetter, BCBS, CIGNA, First Health, Harvard Pilgrim, Humana, MEDICA, MVP Health Plan, Medicare Advantage, Molina, Multiplan, PacificSource, Premera, Regence, Tufts, UHC, and WPS Group. Additionally, employees have the option to choose between Premera Blue Cross or Kaiser Permanente Health Plan of Washington. Premera Blue Cross plans utilize a healthcare provider network, whereas Kaiser Permanente's HMO Core Plan offers integrated services with benefits coordinated through network providers, emphasizing small copays for in-network services and emergency coverage only outside the network.
What awards or recognition has Fred Hutchinson Cancer Research Center received?
Fred Hutchinson Cancer Research Center in Seattle, Washington, is renowned for its significant contributions to cancer research and care. It has merged with Seattle Cancer Care Alliance under UW Medicine, creating a unified, independent nonprofit organization dedicated to adult cancer research and care. The center excels in business development, boasting successful ventures like Juno Therapeutics and Adaptive Biotechnologies, and actively works to improve community health through its Community Grants Program.